95P Improving real-world survival in late-stage NSCLC across the pre-immunotherapy, COVID, and post-COVID eras: A nationwide HeLP3 analysis (2011-2024) | Researchclopedia
95P Improving real-world survival in late-stage NSCLC across the pre-immunotherapy, COVID, and post-COVID eras: A nationwide HeLP3 analysis (2011-2024)